Loss of bone mass is commonly associated with rheumatoid arthritis (RA
) and is increasingly considered to be due to the increased activity o
f bone-resorbing osteoclasts. Gold salts such as auranofin (AF), aurot
hioglucose (ATG) and aurothiomalate (ATM) have beneficial therapeutic
effects in RA, hut their mechanisms(s) of action is not well understoo
d. In the present study we have examined the effects of these 3 gold s
alts on osteoclastic bone resorption in vitro, using the bone slice as
say where bovine cortical bone slices are resorbed by osteoclasts disa
ggregated from the long bones of neonatal rats. All 3 gold sails inhib
ited osteoclastic bone resorption with IC50 values of AF = 0.1 mu g/ml
, ATG and ATM = 1 mu g/ml. All 3 compounds caused 3 decreased survival
of osteoclasts on bone slices at high concentrations indicating a cyt
otoxic effect that was also observed in a cytotoxicity assay with oste
oblast-like UMR-106 cells. Preincubation of bone slices with various c
oncentrations of AF followed by extensive washing prior to use in the
bone slice assay also resulted in an inhibition of bone resorption (IC
50 = 4 mu g/ml) and osteoclast survival on the bone slices preincubate
d with high concentrations of AF was decreased. Since these effects we
re obtained with therapeutic concentrations of gold salts, these resul
ts indicate that inhibition of osteoclastic bone resorption by gold sa
lts may, at least in part, account for their beneficial effects in RA.